Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma
Background/Aims The performance of machine learning (ML) in predicting the outcomes of patients with hepatocellular carcinoma (HCC) remains uncertain.We aimed to develop risk scores using read more conventional methods and ML to categorize early-stage HCC patients into distinct prognostic groups.Methods The study retrospectively enrolled 1,411 cons